Breaking News Bar

Business News and Information Announces New Stock Index Tracking Companies Seeking Treatments and Vaccines for Swine Flu and Avian Flu

PRINCETON, N.J., April 28 /PRNewswire/ -- Tickerspy (, an investing website featuring nearly 250 unique, proprietary Indexes, announced the creation of the Swine Flu and Bird Flu Stocks Index, which includes among its components Gilead Sciences (Nasdaq: GILD), Generex Biotechnology (Nasdaq: GNBT), Sinovac Biotech (Amex: SVA), Novavax (Nasdaq: NVAX), Dynavax Technologies (Nasdaq: DVAX), AVI BioPharma (Nasdaq: AVII), Hemispherx BioPharma (Amex: HEB), BioCryst Pharmaceuticals (Nasdaq: BCRX), and several others.

The Swine Flu and Bird Flu Stocks Index rose by 22.1% on Monday, April 27, as news coverage tracked the spread of swine flu worldwide. Companies seeking treatments and vaccines for various flu strains drove the Index higher. The Index is up by well over 30% over the last month, though it is down by -30% since the start of 2008. To gain immediate access the Swine Flu and Bird Flu Stocks Index, a complete list of its components, and various charts and related metrics, visit the following link:

Tickerspy Indexes use a "net asset value" calculation and cover a wide range of market sectors and segments, including dry bulk shipping stocks, Chinese solar stocks, Canadian energy trusts, gold and silver stocks, uranium stocks, money center banks, and many more.

About tickerspy:

Tickerspy is a free, stock market-focused website that lets users track proprietary Indexes and institutional holdings. Tickerspy members can also track each other's portfolios and share investment ideas and news. In addition, tickerspy members receive a free, customized daily email that includes portfolio performance, alerts, and news on the stocks they are tracking.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

CONTACT: Marcia Martin, tickerspy, +1-888-278-5515

SOURCE Indie Research Advisors, LLC

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear